Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 451.01 -0.05%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Vertex Pharmaceuticals Incorporated Total Liabilities 2011-2024 | VRTX

Annual Total Liabilities Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.15 B 4.24 B 3.33 B 3.06 B 2.23 B 1.81 B 1.5 B 1.56 B 1.41 B 1.24 B 963 M 1.56 B 1.24 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.15 B 963 M 2.25 B

Quarterly Total Liabilities Vertex Pharmaceuticals Incorporated

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
6.61 B 5.36 B 5.37 B 5.15 B 5.21 B 4.88 B 4.54 B 4.24 B 3.68 B - 3.35 B 3.33 B 3.09 B 3.03 B 3.13 B 3.06 B 3.06 B 3.06 B 3.06 B 2.23 B 2.23 B 2.23 B 2.23 B 1.81 B 1.81 B 1.81 B 1.81 B 1.5 B 1.5 B 1.5 B 1.5 B 1.56 B 1.56 B 1.56 B 1.56 B 1.4 B 1.4 B 1.4 B 1.4 B 1.24 B 1.24 B 1.24 B 1.24 B 963 M 963 M 963 M 963 M 1.52 B 1.52 B 1.52 B 1.52 B 1.24 B 1.24 B 1.24 B 1.24 B

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
6.61 B 963 M 2.35 B